Humanized Monoclonal Antibodies Against IgE Antibodies as Therapy for IgE-Mediated Coronary Syndromes: Are We There Yet?
- 1 June 2020
- journal article
- editorial
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 36 (6) , 816-819
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Serum IgE levels are associated with coronary artery disease severityAtherosclerosis, 2016
- Serum IgE levels in coronary artery diseaseAtherosclerosis, 2016
- Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic managementClinical Chemistry and Laboratory Medicine (CCLM), 2016
- An Extraordinary Case Associated with an Allergic Reaction to Clopidogrel: Coronary Artery Spasm or Kounis Syndrome?Heart, Lung and Circulation, 2015
- IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe–/– miceJournal of Clinical Investigation, 2011
- Nickel allergy, Kounis syndrome and intracardiac metal devicesInternational Journal of Cardiology, 2010
- FcγRIV is a mouse IgE receptor that resembles macrophage FcεRI in humans and promotes IgE-induced lung inflammationJournal of Clinical Investigation, 2008
- Simultaneous exposure of several allergens has an additive effect on multisensitized basophilsAllergy, 2006
- Prediction of Myocardial Infarction in Dyslipidemic Men by Elevated Levels of Immunoglobulin Classes A, E, and G, but Not MArchives of internal medicine (1960), 1998
- Down-regulation of Fc(ε)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibodyThe Journal of Immunology, 1997